Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Daniel Lynch


  • Director at Springworks Therapeutics Inc. (SWTX), 2019-09-17
  • Director at Sesen Bio Inc. (SESN), 2019-06-21
  • Director at Blueprint Medicines Corp (BPMC), 2019-06-20
  • Director at Translate Bio Inc. (TBIO), 2019-06-19
  • Director at Bluebird Bio Inc. (BLUE), 2019-06-10
  • Director at Surface Oncology Inc. (SURF), 2019-06-06
  • Director, Other at Dnib Unwind Inc. (BIND), 2016-08-30
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BPMC $80.42 12,500 Director 174,342 2018-02-14 Filing
BPMC $73.27 3,996 Director 186,842 2018-02-12 Filing
BPMC $74.31 3,748 Director 190,838 2018-02-12 Filing
BPMC $75.15 5,636 Director 194,586 2018-02-12 Filing
BPMC $75.96 2,590 Director 200,222 2018-02-12 Filing